{"title":"叙述","authors":"Jason Mittell","doi":"10.4324/9781315879970-4","DOIUrl":null,"url":null,"abstract":"Post ‑traumatic stress disorder (PTSD) is a common psychiatric illness, usually chronic, with severe implications for the quality of life of the affected person and their family, and which has been increasingly recognized as a Public Health problem. In the last two decades, clinical studies with 3,4 ‑methylenedioxymethamphetamine (MDMA) have been demonstrating its promising role as a psychotherapeutic catalyst in patients with PTSD","PeriodicalId":315345,"journal":{"name":"The Craft of Criticism","volume":"334 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Narrative\",\"authors\":\"Jason Mittell\",\"doi\":\"10.4324/9781315879970-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Post ‑traumatic stress disorder (PTSD) is a common psychiatric illness, usually chronic, with severe implications for the quality of life of the affected person and their family, and which has been increasingly recognized as a Public Health problem. In the last two decades, clinical studies with 3,4 ‑methylenedioxymethamphetamine (MDMA) have been demonstrating its promising role as a psychotherapeutic catalyst in patients with PTSD\",\"PeriodicalId\":315345,\"journal\":{\"name\":\"The Craft of Criticism\",\"volume\":\"334 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Craft of Criticism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4324/9781315879970-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Craft of Criticism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4324/9781315879970-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Post ‑traumatic stress disorder (PTSD) is a common psychiatric illness, usually chronic, with severe implications for the quality of life of the affected person and their family, and which has been increasingly recognized as a Public Health problem. In the last two decades, clinical studies with 3,4 ‑methylenedioxymethamphetamine (MDMA) have been demonstrating its promising role as a psychotherapeutic catalyst in patients with PTSD
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
